Ipswich Investment Management Co., Inc. Eli Lilly & CO Transaction History

Ipswich Investment Management Co., Inc.

$419 Million
Q3 2024

A detailed history of Ipswich Investment Management Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 4,224 shares of LLY stock, worth $3.35 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

4,224

Previous 4,465 5.4%

Holding current value

$3.35 Million

Previous $4.04 Million 7.42%

% of portfolio

0.89%

Previous 0.97%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $186,085 - $231,364	-241 Reduced 5.4%	4,224 $3.74 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $189,915 - $238,168	-262 Reduced 5.54%	4,465 $4.04 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $78,778 - $92,869	-150 Reduced 3.08%	4,727 $2.76 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $158,665 - $218,744	-365 Reduced 6.96%	4,877 $2.62 Million
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $68,394 - $91,451	195 Added 3.86%	5,242 $2.46 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $8,076 - $9,485	-26 Reduced 0.51%	5,047 $1.73 Million
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $543,744 - $619,653	-1,834 Reduced 26.55%	5,073 $1.64 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $2,609 - $3,452	-20 Reduced 0.29%	6,907 $1.17 Million
Q1 2020 Apr 09, 2020	SELL	$119.05 - $147.35 $164,289 - $203,343	-1,380 Reduced 16.61%	6,927 $961,000
Q2 2019 Jul 11, 2019	SELL	$110.79 - $129.32 $5,539 - $6,466	-50 Reduced 0.6%	8,307 $920,000
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $147,485 - $173,601	-1,325 Reduced 13.69%	8,357 $1.08 Million
Q4 2018 Jan 15, 2019	BUY	$105.9 - $118.64 $80,060 - $89,691	756 Added 8.47%	9,682 $1.12 Million
Q3 2018 Oct 09, 2018	BUY	$85.86 - $107.31 $766,386 - $957,849	8,926 New	8,926 $958,000
Q2 2018 Jul 18, 2018	SELL	$75.7 - $86.88 $676,455 - $776,359	-8,936 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $56,102 - $66,225	756 Added 9.24%	8,936 $691,000
Q4 2017 Jan 16, 2018	SELL	$81.94 - $87.89 $8,194 - $8,789	-100 Reduced 1.21%	8,180 $691,000
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $638,139 - $708,271	8,280	8,280 $708,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.

Account

Ipswich Investment Management Co., Inc. Eli Lilly & CO Transaction History